Life Biosciences is pushing cellular rejuvenation into the clinic with ER-100, an experimental gene ...
Safety and clinical outcomes of Phase 1 study of VCN-01 (zabilugene almadenorepvec) in refractory retinoblastoma patients to be presented in an invited session at the 41st Asia-Pacific Academy of ...